An interventional study of Arteriography and precision preoperative embolization and Arteriography in Embolization and Pelvic Tumor, sponsored by Peking University People's Hospital. Status unknown. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2022-12-01.
Sponsored by Peking University People's Hospital · Not applicable, Interventional, and Treatment
The main purpose of this study is to assess the efficacy of precision preoperative embolization in decreasing operative blood loss, reducing surgical complications in pelvic tumor surgery. Furthermore the study aims at describing the vascularity in a series of pelvic tumors, and to correlate this with perioperative blood loss.
The main purpose of this study is to assess the efficacy of precision preoperative embolization in decreasing operative blood loss, reducing surgical complications in pelvic tumor surgery，which including poor wound healing，nerve injury，and pelvic organs dysfunction. Furthermore the study aims at describing the vascularity in a series of pelvic tumors,which contains four grade：poor，moderate，rich and abundant and to correlate this with perioperative blood loss.
98 studies on the registry are indexed under Pelvic Neoplasms; 27 are open to participants now.
This study's planned enrollment of 120 is above the median of 42 across 63 interventional studies indexed under Pelvic Neoplasms.
Browse Pelvic Neoplasms studies →Peking University People's Hospital is the lead sponsor of 584 studies on the registry; 233 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
60 patients with pelvic tumors will undergo arteriography and receive transcatheter arterial embolization of pelvic tumors 0-24 hours prior to surgery.
Procedure: Arteriography and precision preoperative embolization
60 patients with pelvic tumors will undergo arteriography and without transcatheter arterial embolization of pelvic tumors prior to surgery.
Procedure: Arteriography
Arteriography and transcatheter arterial embolization of pelvic tumors 0-24 hours prior to surgery.
Also known as: Transcatheter arterial embolization, Therapeutic angiography, Selective arterial embolization
Arteriography of pelvic tumors 0-24 hours prior to surgery.
Perioperative blood loss
Perioperative blood loss measured intraoperatively
Time frame: Measured intraoperatively
Adverse events related to angiography or embolization
Including symptoms of nerve compression, pelvic organ ischemia injury
Time frame: Within 2 postoperative days
Adverse events related to surgery
including poor wound healing，nerve injury，pelvic organ dysfunction
Time frame: Within 30 postoperative days
Vascularization grade of pelvic tumors
it contains four grades：poor、moderate、rich、abundant
Time frame: At the angiographic procedure prior to embolization performed 0-24 hours before surgery
postoperative blood loss
blood loss measured through the drainage within 2 postoperative days
Time frame: Within 2 postoperative days
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Peking University People's Hospital